Suppr超能文献

住院晚期癌症患者呼吸困难:主观和生理相关性。

Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates.

机构信息

Department of Palliative Care and Rehabilitation Medicine, MD Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

J Palliat Med. 2013 Mar;16(3):274-80. doi: 10.1089/jpm.2012.0364. Epub 2013 Feb 11.

Abstract

BACKGROUND AND OBJECTIVE

It is unclear if physiologic measures are useful for assessing dyspnea. We examined the association among the subjective rating of dyspnea according to patients with advanced cancer, caregivers and nurses, and various physiologic measures.

METHODS

We conducted a cross-sectional survey of patients with cancer hospitalized at MD Anderson Cancer Center. We asked patients, caregivers, and nurses to assess the patients' dyspnea at the time of study enrollment independently using a numeric rating scale (0=none, 10=worst). Edmonton Symptom Assessment Scale (ESAS) ratings, causes of dyspnea, vitals, and Respiratory Distress Observation Scale [RDOS] ratings were collected.

RESULTS

A total of 299 patients were enrolled in the study: average age 62 (range 20-98), female 47%, lung cancer 37%, and oxygen use 57%. The median RDOS rating was 2/16 (interquartile range 1-3) and the number of potential causes was 3 (range 2-4), with pleural effusion (n=166, 56%), pneumonia (n=144, 48%), and lung metastasis (n=125, 42%) being the most common. The median intensity of patients' dyspnea at the time of assessment was 3 (interquartile range 0-6) for patients, 4 (interquartile range 1-6) for caregivers, and 2 (interquartile range 0-3) for bedside nurses. Patients' expression of dyspnea correlated moderately with caregivers' (r=0.68, p<0.001) and nurses' (r=0.50, p<0.001) assessments, and weakly with RDOS (r=0.35, p<0.001), oxygen level (r=0.32, p<0.001), and the number of potential causes (r=0.19, p=0.001). In multivariate analysis, patients' dyspnea was only independently associated with ESAS dyspnea (p=0.002) and dyspnea as assessed by caregivers (p<0.001).

CONCLUSION

Patients' level of dyspnea was weakly associated with physiologic measures. Caregivers' perception may be a useful surrogate for dyspnea assessment.

摘要

背景与目的

目前尚不清楚生理指标是否有助于评估呼吸困难。我们研究了根据晚期癌症患者、护理人员和护士的主观呼吸困难评分与各种生理指标之间的关联。

方法

我们对 MD 安德森癌症中心住院的癌症患者进行了横断面调查。我们要求患者、护理人员和护士在研究入组时使用数字评分量表(0=无,10=最严重)独立评估患者的呼吸困难。同时收集 Edmonton 症状评估量表(ESAS)评分、呼吸困难原因、生命体征和呼吸窘迫观察量表[RDOS]评分。

结果

共有 299 例患者入组研究:平均年龄 62 岁(范围 20-98 岁),女性占 47%,肺癌占 37%,吸氧占 57%。RDOS 评分中位数为 2/16(四分位距 1-3),潜在病因数为 3(范围 2-4),最常见的是胸腔积液(n=166,占 56%)、肺炎(n=144,占 48%)和肺转移(n=125,占 42%)。评估时患者呼吸困难的中位强度为 3(四分位距 0-6),护理人员为 4(四分位距 1-6),床边护士为 2(四分位距 0-3)。患者呼吸困难的表达与护理人员(r=0.68,p<0.001)和护士(r=0.50,p<0.001)的评估中度相关,与 RDOS(r=0.35,p<0.001)、氧水平(r=0.32,p<0.001)和潜在病因数(r=0.19,p=0.001)弱相关。多变量分析显示,患者呼吸困难仅与 ESAS 呼吸困难(p=0.002)和护理人员评估的呼吸困难(p<0.001)独立相关。

结论

患者呼吸困难程度与生理指标相关性较弱。护理人员的感知可能是评估呼吸困难的有用替代指标。

相似文献

1
Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates.
J Palliat Med. 2013 Mar;16(3):274-80. doi: 10.1089/jpm.2012.0364. Epub 2013 Feb 11.
2
Underdetection and Undertreatment of Dyspnea in Critically Ill Patients.
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1377-1384. doi: 10.1164/rccm.201805-0996OC.
3
Dyspnea and quality of life indicators in hospice patients and their caregivers.
Health Qual Life Outcomes. 2003 Apr 17;1:9. doi: 10.1186/1477-7525-1-9.
4
Validity, Reliability, and Diagnostic Accuracy of the Respiratory Distress Observation Scale for Assessment of Dyspnea in Adult Palliative Care Patients.
J Pain Symptom Manage. 2019 Feb;57(2):304-310. doi: 10.1016/j.jpainsymman.2018.10.506. Epub 2018 Nov 2.
5
Hospice patient and caregiver congruence in reporting patients' symptom intensity.
Cancer Nurs. 2003 Apr;26(2):113-8. doi: 10.1097/00002820-200304000-00004.
6
Symptom correlates of dyspnea in advanced cancer patients using the Edmonton Symptom Assessment System.
Support Care Cancer. 2020 Jan;28(1):87-98. doi: 10.1007/s00520-019-04787-0. Epub 2019 Apr 13.
8
Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer Patients.
Oncologist. 2015 Sep;20(9):1092-8. doi: 10.1634/theoncologist.2015-0026. Epub 2015 Jul 23.
9
Personalized Goal for Dyspnea and Clinical Response in Advanced Cancer Patients.
J Pain Symptom Manage. 2019 Jan;57(1):79-85. doi: 10.1016/j.jpainsymman.2018.10.492. Epub 2018 Oct 16.
10
Trajectory of Dyspnea and Respiratory Distress among Patients in the Last Month of Life.
J Palliat Med. 2018 Feb;21(2):194-199. doi: 10.1089/jpm.2017.0265. Epub 2017 Aug 17.

引用本文的文献

2
Dyspnea-Related Dimensions And Self-Efficacy: Associations With Well-Being in Advanced Lung Cancer.
J Pain Symptom Manage. 2024 May;67(5):366-374.e1. doi: 10.1016/j.jpainsymman.2024.01.032. Epub 2024 Feb 1.
3
Higher Lifetime Stress and Symptom Burden Contribute to the Occurrence of Shortness of Breath.
Semin Oncol Nurs. 2023 Oct;39(5):151471. doi: 10.1016/j.soncn.2023.151471. Epub 2023 Jul 25.
4
Effect of Dexmedetomidine for Palliative Sedation for Refractory Dyspnoea in Patients with Terminal-Stage Cancer.
Cancer Manag Res. 2023 Mar 22;15:291-299. doi: 10.2147/CMAR.S404934. eCollection 2023.
5
Systematic review of the literature on the occurrence and characteristics of dyspnea in oncology patients.
Crit Rev Oncol Hematol. 2023 Jan;181:103870. doi: 10.1016/j.critrevonc.2022.103870. Epub 2022 Nov 12.
6
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.
Lancet Oncol. 2022 Oct;23(10):1321-1331. doi: 10.1016/S1470-2045(22)00508-3. Epub 2022 Sep 7.
7
Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life.
Cancer Res Treat. 2022 Jul;54(3):661-670. doi: 10.4143/crt.2022.143. Epub 2022 Jun 30.
8
Research policy in supportive care and palliative care for cancer dyspnea.
Jpn J Clin Oncol. 2022 Mar 3;52(3):260-265. doi: 10.1093/jjco/hyab193.
10
Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer.
ESMO Open. 2020;5 Suppl 1(Suppl 1):e000603. doi: 10.1136/esmoopen-2019-000603. Epub 2020 Sep 30.

本文引用的文献

1
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.
Am J Respir Crit Care Med. 2012 Feb 15;185(4):435-52. doi: 10.1164/rccm.201111-2042ST.
2
Quantity, design, and scope of the palliative oncology literature.
Oncologist. 2011;16(5):694-703. doi: 10.1634/theoncologist.2010-0397. Epub 2011 Apr 6.
3
Potentially modifiable predictors of mortality in patients treated with long-term oxygen therapy.
Respir Med. 2011 Mar;105(3):470-6. doi: 10.1016/j.rmed.2010.08.012. Epub 2010 Sep 16.
4
A Respiratory Distress Observation Scale for patients unable to self-report dyspnea.
J Palliat Med. 2010 Mar;13(3):285-90. doi: 10.1089/jpm.2009.0229.
5
Patients who are near death are frequently unable to self-report dyspnea.
J Palliat Med. 2009 Oct;12(10):881-4. doi: 10.1089/jpm.2009.0082.
6
Characteristics and correlates of dyspnea in patients with advanced cancer.
J Palliat Med. 2009 Jan;12(1):29-36. doi: 10.1089/jpm.2008.0158.
9
Psychometric testing of a respiratory distress observation scale.
J Palliat Med. 2008 Jan-Feb;11(1):44-50. doi: 10.1089/jpm.2007.0090.
10
Which measurement scales should we use to measure breathlessness in palliative care? A systematic review.
Palliat Med. 2007 Apr;21(3):177-91. doi: 10.1177/0269216307076398. Epub 2007 Mar 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验